ProPhase Labs, Inc.

PRPH | OTC | CIK: 0000868278 | SIC: 2834 Pharmaceutical Preparations | active
Old Bridge, New Jersey
ProPhase Labs, Inc. is a diversified biotech, genomics, and consumer products company. It offers whole genome sequencing through Nebula Genomics and DNA Complete, develops novel drugs and dietary supplements via ProPhase BioPharma (PBIO), markets TK Supplements dietary supplements, and previously provided COVID-19 PCR and antigen diagnostic testing. The company also owns worldwide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostic screening test.
personal-genomicsdiagnosticsdietary-supplementsdrug-developmentesophageal-cancer-screeningmiddle-east-and-north-africa-(mena)clia-(clinical-laboratory-improvement-amendments)fda-laboratory-developed-test-(ldt)-regulationspcr-(polymerase-chain-reaction)
AI agents: Get this data as structured JSON (~200 tokens):
https://origin.rootz.global/api/company/PRPH
Profile | Timeline | SEC Filings | People

Products

NameTypeDescription
Whole Genome SequencingserviceHuman genomic testing and related services offered through Nebula Genomics, Inc. and DNA Complete, Inc.
BE-Smart Esophageal Pre-Cancer Diagnostic Screening TestserviceDiagnostic test for early detection of esophageal cancer risk, currently under development as a Laboratory Developed Test.
TK SupplementshardwareDietary supplements developed and marketed under the TK Supplements brand.
COVID-19 PCR TestingservicePolymerase chain reaction testing for COVID-19 and Influenza A and B, previously offered through ProPhase Diagnostics.
COVID-19 Rapid Antigen TestingserviceRapid antigen testing for COVID-19, previously offered through ProPhase Diagnostics.

Partnerships

PartnerTypeDescription
mProbe, Inc.developmentCollaboration for continued development and optimization of the BE-Smart Esophageal Pre-Cancer diagnostic screening test using clinical proteomics.
Mayo Clinic (Dr. Christopher Hartley)developmentCollaboration announced March 2023 for development of BE-Smart Esophageal Pre-Cancer diagnostic screening test.

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/PRPH/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub